Kalobios Pharmaceuticals (NASDAQ:KBIO) - Martin Shkreli Makes 1,080% On Penny Stock Days After...
KaloBios Pharmaceuticals Inc (NASDAQ: KBIO) is a monoclonal antibody therapeutics company that traded as a penny stock as recently as this Monday. The company now trades above the...
Hasnain says:
"According to a Form 4 filing with the SEC, Shkreli bought 500,169 shares at $0.61 apiece, with the remaining stakes purchased between $1.43 and $2.43"
Given that the stock is now trading at $19, that's a nice tidy profit
Posted on 2015-11-19T04:19:21+0000